McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a June 12, 2017 edition of Law360.com in an article entitled, “6 Key Takeaways From High Court’s Big Biosimilar Ruling.” The U.S. Supreme Court delivered a smashing win for the youthful biosimilars industry by swatting away efforts to delay the lower-cost medicines, and its ruling teed up new battles for lower courts and maybe even Congress, attorneys say. Here are six key takeaways from Monday’s ruling. View the article
